ni.kravchenko

TL2 · Gdańsk

Contributes reviews on supplier material. Based in Gdańsk.

Joined 9 February 2025 · last posted 7d

99 posts, newest first. Showing up to 150.

How shortages have affected compounding permissions Replied, post #57 · Access › Shortages · 21 Jul 2026 · 0 likes Post #54 is the version of this I will quote in future. One addition. Shortages came up in a thread eighteen months ago and was answered well. I cannot find it, which…
What a certificate commits its issuer to Replied, post #46 · Analytics › COA interpretation · 17 Jul 2026 · 10 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. The distinction between release testing and characterisation is one industrial…
I have no scientific background — can I still follow the analytics categories? Replied, post #33 · Start Here › Welcome · 5 Jul 2026 · 32 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume. The part I am…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #50 · Analytics › Home & field testing · 3 Jul 2026 · 20 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. The reasoning is more…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #61 · Evidence › Journal club · 26 Jun 2026 · 4 likes Building on post #60 rather than restating it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 25 Jun 2026 · 10 likes Narrowing post #13, because the general version has more than one answer. Cagrilintide alone is discussed less than in combination because the published data is almost…
Revisiting: How this community labels and discusses unrefereed work Replied, post #2 · marked as the solution · Evidence › Preprints · 15 Jun 2026 · 31 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
Racemisation and why it is invisible to a mass measurement Replied, post #35 · Analytics › Impurities & related substances · 10 Jun 2026 · 33 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
Private prescribing in the UK: what is actually involved Replied, post #34 · Regional › UK & Ireland · 9 Jun 2026 · 1 like Two sentences on private prescribing and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #23 · Compounds › Secretagogues & GH axis · 4 Jun 2026 · 19 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Adding the boring version of secretagogues and glucose tolerance, because the…
Historical amylin analogues and what happened to them Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 26 May 2026 · 5 likes Adding the measurement that post #9 says would settle it. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the…
Spreadsheets: an appreciation — what changed since Replied, post #47 · Lounge › Off topic · 20 May 2026 · 3 likes Adding a reference point for Spreadsheets. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
An 18-month record including the parts that went badly Replied, post #17 · Outcomes › Progress reports · 16 May 2026 · 11 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #2 · Compounds › Secretagogues & GH axis · 4 May 2026 · 19 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
Blind submission and why it changes minds — the long version Replied, post #56 · Sourcing › Independent verification · 4 May 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. I would want to see it done twice before…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #7 · Analytics › COA interpretation · 28 Apr 2026 · 25 likes I read the earlier replies on field-by-field walk through a certificate twice before writing this, because I had assumed the opposite and wanted to be sure I was…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #26 · Clinical › Bloodwork · 27 Apr 2026 · 1 like Two sentences on Liver enzymes drifting and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #16 · Devices › Syringes & needles · 16 Apr 2026 · 18 likes What I can speak to on 0.3 ml versus 0.5 ml is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Choosing which test to pay for, given a fixed budget Replied, post #66 · Sourcing › Independent verification · 12 Apr 2026 · 1 like Where I part company with post #62, and it is a narrow parting. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
Why the titration planner refuses to produce a schedule below a floor Replied, post #58 · Data & Tools › Calculators · 6 Apr 2026 · 0 likes Where I have landed on titration planner refuses, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
A widely repeated interaction claim that turns out to be unsupported Replied, post #41 · Practice › Interactions · 31 Mar 2026 · 11 likes Post #38 is right about the mechanism and I think understates the practical bit. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E,…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #19 · Meta › Announcements · 21 Mar 2026 · 5 likes Post #15 describes the usual case. This is about the unusual one. Adding the boring version of Trust level 3 requirements, because the interesting version keeps getting…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #18 · Analytics › Impurities & related substances · 19 Mar 2026 · 4 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. The confident answers on Residual solvents and scavengers and the well-sourced…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #52 · Start Here › Welcome · 11 Mar 2026 · 30 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #49 · Research Methods › Statistics · 9 Mar 2026 · 0 likes Taking post #46 at face value and following it one step further. Two questions I would want answered before drawing anything from the Measurement error in home scales…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #11 · Compounds › Repair & healing peptides · 8 Mar 2026 · 29 likes Adding a small correction to the Reading a preclinical wound-healing model summary above rather than a disagreement with it. The substance holds; one of the figures is…
Interpreting a result that disagrees with the supplier's certificate Replied, post #150 · Sourcing › Independent verification · 5 Mar 2026 · 0 likes A definition problem is doing most of the work in this interpreting a result discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #100 · Evidence › Study critique · 2 Mar 2026 · 6 likes Coming back to post #96, because the follow-up matters more than the original answer. Per-protocol and intention-to-treat analyses answer different questions and…
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #16 · Compounds › Secretagogues & GH axis · 26 Feb 2026 · 2 likes I disagree with the framing of Evidence quality above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Measurement error in a self-reported exposure Replied, post #68 · Evidence › Study critique · 25 Feb 2026 · 32 likes Worth stating the null on measurement error before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
A single out-of-range value on an otherwise normal panel Replied, post #17 · Clinical › Bloodwork · 24 Feb 2026 · 14 likes Coming back to post #13, because the follow-up matters more than the original answer. Practical note on single out-of-range value: write down what you expect before you…
Choosing which test to pay for, given a fixed budget Replied, post #3 · Sourcing › Independent verification · 22 Feb 2026 · 19 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Research-use-only labelling: what it means and what it does not Replied, post #106 · Sourcing › Regulatory · 21 Feb 2026 · 1 like Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 21 Feb 2026 · 12 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #79 · Outcomes › Progress reports · 18 Feb 2026 · 2 likes Day-to-day body mass varies by more than a kilogram on hydration, glycogen and gut contents alone. A weekly reading is one noisy sample of that distribution.
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #38 · Practice › Storage & stability · 11 Feb 2026 · 20 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That is all I can say without guessing.
Gastro-oesophageal reflux: improving or worsening? Replied, post #14 · Clinical › Comorbidities · 26 Jan 2026 · 20 likes Second this, and I would have said it less carefully.
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #8 · Outcomes › Body composition · 16 Jan 2026 · 15 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology. For what it…
Thyroid function tests during substantial weight change Replied, post #150 · Clinical › Bloodwork · 26 Nov 2025 · 10 likes Adding the measurement that post #149 says would settle it. Offering a way to settle thyroid function tests during substantial rather than another opinion about it. Two…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #20 · Compounds › Oral incretins · 26 Nov 2025 · 6 likes Post #18 put the caveat in the right place and I want to underline it. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly.…
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #3 · marked as the solution · Practice › Storage & stability · 21 Nov 2025 · 23 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Pen dose counters: what a click does and does not guarantee Replied, post #98 · Devices › Pens & autoinjectors · 19 Nov 2025 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
New subcategory: rationale and scope Replied, post #120 · Meta › Announcements · 25 Oct 2025 · 0 likes Adding a small correction to the new subcategory summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #43 · Compounds › Tirzepatide · 21 Oct 2025 · 20 likes Adding the measurement that post #40 says would settle it. Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing…
Pinch or no pinch, and how needle length changes the answer Replied, post #119 · Practice › Administration · 19 Oct 2025 · 22 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #92 · Devices › Cold chain · 19 Oct 2025 · 0 likes Adding the boring version of Airline travel, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #60 · Sourcing › Vendor reports · 21 Sep 2025 · 9 likes That is a fair summary of where the discussion has got to.
Temperature loggers worth the money Replied, post #28 · Devices › Cold chain · 10 Sep 2025 · 31 likes Before the thread moves on from temperature loggers worth the money — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #76 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Small correction to my own earlier position on Aggregated purity results across four. I had the units the wrong way round, which changes the conclusion by an order of…
Specification in the result column: why that is a meaningful error Replied, post #40 · Analytics › COA interpretation · 5 Sep 2025 · 1 like That is clearer than the version I had in my head. Thank you.
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #17 · Practice › Reconstitution · 26 Aug 2025 · 9 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. One of those…
How to research a compound with no human data without deceiving yourself Replied, post #97 · Compounds › Other compounds · 4 Aug 2025 · 11 likes Where I part company with post #95, and it is a narrow parting. Several compounds discussed here have no published human pharmacokinetics at all. That means half-life…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #38 · Analytics › Mass spectrometry · 3 Aug 2025 · 7 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. Written from notes…
How to research a compound with no human data without deceiving yourself Replied, post #74 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #64 · Sourcing › Regulatory · 30 Jul 2025 · 13 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Where I would look next, rather…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 12 likes Picking up post #41: that is the part I would want checked first. The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #24 · Practice › Reconstitution · 12 Jul 2025 · 21 likes Post #22 describes the usual case. This is about the unusual one. Preservative effectiveness is tested against a defined microbial challenge under defined conditions.…
System suitability injections: if they failed, the run did not happen Replied, post #13 · Analytics › HPLC & UHPLC · 9 Jul 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #85 · Wellbeing › Mental health · 8 Jul 2025 · 1 like The version of history of disordered eating that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
Journal club: SURMOUNT-1, read without the press release Replied, post #152 · Evidence › Journal club · 5 Jul 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #46 · Compounds › Repair & healing peptides · 21 Jun 2025 · 6 likes Picking up post #43: that is the part I would want checked first. What I can speak to on TB-500 and thymosin beta-4 is narrow, so I will keep it narrow rather than…
EU-wide position versus national implementation Replied, post #12 · Regional › European Union · 20 Jun 2025 · 27 likes Summarising the eu-wide position versus national implementation thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #140 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 0 likes That is a fair summary of where the discussion has got to.
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #9 · Compounds › Repair & healing peptides · 14 Jun 2025 · 27 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #45 · Regional › UK & Ireland · 14 Jun 2025 · 0 likes Practical note on Pharmacy supply: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Half-life, steady state, and accumulation worked through Replied, post #25 · Pharmacology › Pharmacokinetics · 26 May 2025 · 0 likes On post #21 — agreed on the reasoning, with one qualification. Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #36 · Compounds › Oral incretins · 23 May 2025 · 6 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Antibiotics and a course of something with delayed emptying Replied, post #35 · Practice › Interactions · 6 May 2025 · 6 likes Taking post #34 at face value and following it one step further. The practical version of antibiotics is three sentences long. The rigorous version is three pages and…
Adjudicated events and why the definition matters — the long version Replied, post #118 · Evidence › Trials · 25 Apr 2025 · 22 likes That reframing is the whole thing. The facts I already had.
A supplier that answers analytical questions with restated claims Replied, post #62 · Sourcing › Red flags · 22 Apr 2025 · 1 like If someone has run supplier properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Reading an MS report that only gives you a single number Replied, post #57 · Analytics › Mass spectrometry · 19 Apr 2025 · 0 likes Post #55 describes the usual case. This is about the unusual one. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is…
About the Body composition category Replied, post #5 · Outcomes › Body composition · 16 Apr 2025 · 0 likes Circumference measurements at marked sites, taken consistently, track composition change better than most people expect for the cost. The disagreement above is smaller…
Requesting a page: what makes a good request Replied, post #53 · Documentation › Wiki requests · 11 Apr 2025 · 1 like The arithmetic in post #50 is right; the assumption feeding it is the part to check. Translation suggestions: if a maintained page should exist in another language,…
A certificate with no method stated: what can you conclude? Replied, post #43 · Analytics › COA interpretation · 8 Apr 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
A certificate whose chromatogram axes do not match its stated method Replied, post #7 · Sourcing › Red flags · 24 Mar 2025 · 32 likes Following this. I have the same question and no better information than the first post.
Maintainer handover: how it works Replied, post #56 · Meta › Wiki maintenance · 17 Mar 2025 · 0 likes Two claims get bundled together under maintainer handover and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Follow-up: What other technical communities get right that we do not Replied, post #40 · Lounge › Off topic · 15 Mar 2025 · 7 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #102 · Pharmacology › Receptor biology · 15 Mar 2025 · 7 likes Where a mechanism is proposed to explain an effect, the useful follow-up is what observation would distinguish it from the alternative. Most mechanistic threads here…
Assessing a warm arrival: the decision process Replied, post #13 · Sourcing › Logistics · 13 Mar 2025 · 6 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. The number is defensible.…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #137 · Sourcing › Regulatory · 5 Mar 2025 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #26 · Practice › Interactions · 1 Mar 2025 · 14 likes This follows post #23 rather than contradicting it. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction…
Validating a method you did not develop — does this still hold? Replied, post #27 · Analytics › Method validation · 20 Feb 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #5 · Clinical › Bloodwork · 9 Feb 2025 · 0 likes An observation about hba1c lag that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
What we do not know about retatrutide, listed explicitly Replied, post #87 · Compounds › Retatrutide · 8 Feb 2025 · 27 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Canadian access and provincial variation Replied, post #45 · Regional › North America · 2 Feb 2025 · 0 likes Post #44 answers the question as asked. The question underneath it is different. What I would check first on canadian access and provincial variation is whether the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 1 Feb 2025 · 18 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Levothyroxine timing: a real interaction with a simple fix Replied, post #16 · Practice › Interactions · 21 Dec 2024 · 1 like Coming back to post #12, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #79 · Access › Insurance & coverage · 20 Dec 2024 · 3 likes Reading rather than answering, but this is the post I would point somebody at.
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #14 · Practice › Dosing & titration · 6 Dec 2024 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. Two questions I would want answered before drawing anything from the Holding a dose data…
SURPASS-2 and the comparator dose question that will not go away Replied, post #63 · Compounds › Tirzepatide · 24 Nov 2024 · 12 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Fixed versus detachable needles: the trade-offs Replied, post #15 · Devices › Syringes & needles · 23 Nov 2024 · 14 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. The practical version of fixed versus detachable needles is three sentences long.…
Time to steady state after a dose increase Replied, post #134 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 7 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #2 · Practice › Reconstitution · 30 Oct 2024 · 24 likes Bookmarking this. I will come back when I have something worth adding.
Gallbladder disease risk with rapid weight loss Replied, post #18 · Clinical › Comorbidities · 11 Oct 2024 · 17 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. That much is documented. The rest is…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #11 · Clinical › Bloodwork · 5 Sep 2024 · 16 likes That is clearer than the version I had in my head. Thank you.
Coming back to: Purity assay versus content assay: two different numbers Replied, post #17 · Analytics › COA interpretation · 8 Aug 2024 · 21 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #12 · Analytics › Method validation · 7 Aug 2024 · 9 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
How this community labels and discusses unrefereed work Replied, post #96 · Evidence › Preprints · 19 Jul 2024 · 12 likes Adding the measurement that post #93 says would settle it. The reason community labels keeps being re-asked is that the answer is conditional and people quote it…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #3 · Compounds › Retatrutide · 15 Jul 2024 · 4 likes Clear enough that I do not think I have a follow-up, which is unusual.